• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与肺结核相关的肠道微生物群及抗结核药物引起的微生态失调。

Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs.

机构信息

MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.

Shenzhen Engineering Center for Tuberculosis, Shenzhen Key Lab. of Infection & Immunity, Shenzhen Third People's Hospital, Shenzhen University, Shenzhen 518112, China.

出版信息

J Infect. 2019 Apr;78(4):317-322. doi: 10.1016/j.jinf.2018.08.006. Epub 2018 Aug 11.

DOI:10.1016/j.jinf.2018.08.006
PMID:30107196
Abstract

BACKGROUND

An improved understanding of the gut microbiota could lead to better strategies for the diagnosis, therapy and prophylaxis of tuberculosis (TB). The impact of both Mycobacterium tuberculosis (Mtb) infection and anti-TB treatment on the gut microbiota has rarely been studied.

METHODS

We characterized the diversity and composition of the gut microbiota in pulmonary TB patients as well as the effects of anti-TB drugs on the gut microbiota.

RESULTS

Pulmonary Mtb infection led to a minor decrease in the α diversity of the gut microbiota when compared to healthy controls, which mainly resulted from changes in the relative abundance of the members of genus Bacteroides. Anti-TB therapy caused a rapid, significant alteration in the community structure. The relative abundance of members of genus Clostridiales of the phylum Firmicutes significantly decreased during anti-TB treatment, while many members of genus Bacteroides, including Bacteroides OTU230 and Bacteroides fragilis, were among the taxa that increased. OTU8 and OTU2972 assigned to family Erysipelotrichaceae of the phylum Firmicutes showed a dramatic increase 1 week after the start of therapy, while the other members of this family decreased.

CONCLUSIONS

Pulmonary TB and anti-TB treatment caused a distinct dysbiosis of the gut microbiota. Our study contributes valuable information implying potential links between the gut microbiota and TB.

摘要

背景

对肠道微生物组的深入了解可能会为结核病(TB)的诊断、治疗和预防提供更好的策略。分枝杆菌(Mtb)感染和抗 TB 治疗对肠道微生物组的影响很少被研究。

方法

我们描述了肺结核患者肠道微生物组的多样性和组成,以及抗 TB 药物对肠道微生物组的影响。

结果

与健康对照相比,肺部 Mtb 感染导致肠道微生物组的 α 多样性略有下降,这主要是由于属 Bacteroides 成员的相对丰度发生了变化。抗 TB 治疗会导致群落结构迅速、显著改变。厚壁菌门 Firmicutes 的属 Clostridiales 的成员相对丰度在抗 TB 治疗期间显著下降,而属 Bacteroides 中的许多成员,包括 Bacteroides OTU230 和 Bacteroides fragilis,是增加的分类群之一。Firmicutes 的属 Erysipelotrichaceae 的 OTU8 和 OTU2972 在治疗开始后 1 周内急剧增加,而该科的其他成员则减少。

结论

肺结核和抗 TB 治疗导致肠道微生物组明显失调。我们的研究提供了有价值的信息,暗示了肠道微生物组与结核病之间可能存在联系。

相似文献

1
Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs.与肺结核相关的肠道微生物群及抗结核药物引起的微生态失调。
J Infect. 2019 Apr;78(4):317-322. doi: 10.1016/j.jinf.2018.08.006. Epub 2018 Aug 11.
2
Gut Mycobiota Dysbiosis in Pulmonary Tuberculosis Patients Undergoing Anti-Tuberculosis Treatment.肺结核患者抗结核治疗中肠道微生物群落失调。
Microbiol Spectr. 2021 Dec 22;9(3):e0061521. doi: 10.1128/spectrum.00615-21. Epub 2021 Dec 15.
3
Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy.纵向分析显示,常规抗结核治疗会引发持久的肠道菌群失调。
Microbiome. 2017 Jul 7;5(1):71. doi: 10.1186/s40168-017-0286-2.
4
The Microbiota of Human Lung of Pulmonary Tuberculosis and the Alteration Caused by Anti-tuberculosis Drugs.人类肺部微生物群与抗结核药物引起的改变:肺结核的肺部微生物群。
Curr Microbiol. 2022 Sep 19;79(11):321. doi: 10.1007/s00284-022-03019-9.
5
The Gut Microbiome Signatures Discriminate Healthy From Pulmonary Tuberculosis Patients.肠道微生物组特征可区分健康人与肺结核患者。
Front Cell Infect Microbiol. 2019 Apr 3;9:90. doi: 10.3389/fcimb.2019.00090. eCollection 2019.
6
Profiling the airway in the macaque model of tuberculosis reveals variable microbial dysbiosis and alteration of community structure.结核分枝杆菌猕猴模型的气道分析显示微生物失调和群落结构改变具有可变性。
Microbiome. 2018 Oct 9;6(1):180. doi: 10.1186/s40168-018-0560-y.
7
Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria.铋四联疗法根除幽门螺杆菌会导致肠道微生物群落失调,变形菌门相对丰度增加,拟杆菌门和放线菌门相对丰度减少。
Helicobacter. 2018 Aug;23(4):e12498. doi: 10.1111/hel.12498. Epub 2018 Jun 13.
8
Systemic proinflammation after Mycobacterium tuberculosis infection was correlated to the gut microbiome in HIV-uninfected humans.结核分枝杆菌感染后全身炎症与 HIV 未感染者的肠道微生物组有关。
Eur J Clin Invest. 2019 May;49(5):e13068. doi: 10.1111/eci.13068. Epub 2019 Mar 15.
9
Distinct lung microbial community states in patients with pulmonary tuberculosis.肺结核患者肺部微生物群落的不同状态。
Sci China Life Sci. 2020 Oct;63(10):1522-1533. doi: 10.1007/s11427-019-1614-0. Epub 2020 Apr 14.
10
Gut bacterial and fungal dysbiosis in tuberculosis patients.肺结核患者的肠道细菌和真菌生态失调
BMC Microbiol. 2024 Apr 25;24(1):141. doi: 10.1186/s12866-024-03275-8.

引用本文的文献

1
Gut microbiota and tuberculosis.肠道微生物群与结核病
Imeta. 2025 Jun 22;4(4):e70054. doi: 10.1002/imt2.70054. eCollection 2025 Aug.
2
Gut microbiota profile in newly diagnosed pulmonary tuberculosis patients: an exploratory pilot study in southern India.新诊断肺结核患者的肠道微生物群概况:印度南部的一项探索性初步研究。
Gut Pathog. 2025 Aug 11;17(1):59. doi: 10.1186/s13099-025-00736-x.
3
Gut microbiota and tuberculosis infection: interaction and therapeutic potential.肠道微生物群与结核病感染:相互作用及治疗潜力
Gut Microbes. 2025 Dec;17(1):2531201. doi: 10.1080/19490976.2025.2531201. Epub 2025 Jul 14.
4
Metabolic and immune consequences of antibiotic related microbiome alterations during first-line tuberculosis treatment in Bamako, Mali.马里巴马科一线抗结核治疗期间抗生素相关微生物组改变的代谢和免疫后果
Front Immunol. 2025 May 14;16:1561459. doi: 10.3389/fimmu.2025.1561459. eCollection 2025.
5
Changes in gut microbiome following anti-tuberculosis treatment: a prospective cohort from eastern China.抗结核治疗后肠道微生物群的变化:来自中国东部的一项前瞻性队列研究
BMC Infect Dis. 2025 Apr 1;25(1):453. doi: 10.1186/s12879-025-10800-1.
6
The association between the gut microbiome and antituberculosis drug-induced liver injury.肠道微生物群与抗结核药物性肝损伤之间的关联。
Front Pharmacol. 2025 Mar 10;16:1512815. doi: 10.3389/fphar.2025.1512815. eCollection 2025.
7
Disorders of gut microbiota and fecal-serum metabolic patterns are associated with pulmonary tuberculosis and pulmonary tuberculosis comorbid type 2 diabetes mellitus.肠道微生物群紊乱和粪便-血清代谢模式与肺结核及肺结核合并2型糖尿病相关。
Microbiol Spectr. 2025 Aug 5;13(8):e0177224. doi: 10.1128/spectrum.01772-24. Epub 2025 Mar 14.
8
Peripheral blood microbiome signature and Mycobacterium tuberculosis-derived rsRNA as diagnostic biomarkers for tuberculosis in human.外周血微生物组特征和结核分枝杆菌衍生的环状小RNA作为人类结核病的诊断生物标志物。
J Transl Med. 2025 Feb 19;23(1):204. doi: 10.1186/s12967-025-06190-2.
9
Reduced gut microbiota diversity in ulcerative colitis patients with latent tuberculosis infection during vedolizumab therapy: insights on prophylactic anti-tuberculosis effects.维多珠单抗治疗期间潜伏性结核感染的溃疡性结肠炎患者肠道微生物群多样性降低:对预防性抗结核作用的见解
BMC Microbiol. 2024 Dec 27;24(1):543. doi: 10.1186/s12866-024-03705-7.
10
Gut microbiota: a crucial player in the combat against tuberculosis.肠道微生物群:抗击结核病的关键因素。
Front Immunol. 2024 Oct 22;15:1442095. doi: 10.3389/fimmu.2024.1442095. eCollection 2024.